人类疾病病毒媒介基因疗法的CRISPR-Cas编辑技术:机制,进展和挑战
Boris Kantor1,2,3,4, Leanne Duke1,2, Pradeep G Bhide2,3
1Viral Vector and Gene Editing Cores, Florida Institute for Pediatric Rare Diseases, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Molecular therapy. Nucleic acids
|January 7, 2026
概括
使用腺相关病毒 (AAV) 和病毒载体 (LVs) 的基因疗法取得了重大进展. 新兴的CRISPR-Cas基因编辑技术为遗传疾病提供了新的治疗潜力.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 医学 医学 医学 医学 医学
背景情况:
- 自2017年以来,基因疗法领域迅速发展,批准了基于腺相关病毒 (AAV) 的疗法.
- 许多病毒基因疗法产品,主要使用AAV和lentiviral vector (LVs),已获得美国FDA的批准.
- 病毒载体效率,制造和商业利益的改善推动了临床采用.
研究的目的:
- 审查当前的基因治疗疗法及其病毒载体,重点关注LV和AAV.
- 为提供基因疗法领域当前状态的概述.
- 突出挑战和未来的潜力,特别是病毒CRISPR-Cas技术.
主要方法:
- 审批基因疗法产品及其病毒载体系统的审查.
- 分析病毒载体介导的基因转移和制造方面的进展.
- 检查基因疗法中集群定期间隔的短平行体重复 (CRISPR) 和CRISPR-Cas技术.
主要成果:
- 基因疗法取得了显著进展,许多产品依赖于腺相关载体 (AAV) 和病毒载体 (LV).
- 克里斯普尔-卡斯技术代表了治疗遗传疾病的下一代基因编辑.
- 该领域的特点是快速临床采用和持续的创新.
结论:
- 病毒载体,特别是AAV和LV,是当前基因治疗成功的核心.
- CRISPR-Cas基因编辑对未来的治愈治疗有着巨大的前景.
- 基因疗法的临床应用仍然面临挑战,特别是在病毒CRISPR-Cas技术方面.
相关概念视频
01:59CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
01:28CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
00:49What is Genetic Engineering?
79.6K
Overview
79.6K
02:53CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
01:29Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928